Compare Bitdeer Technologies Group (BTDR) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bitdeer Technologies Group vs IDEXX Laboratories, Inc. — how do they compare? Bitdeer Technologies Group trades at $9.02 (market cap $2.36B), while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 19.6× Bitdeer Technologies Group's market cap. Which is the better fit depends on your goals.
| BTDR | IDXX | |
|---|---|---|
Market Cap | $2.36B | $46.22B |
Sector | Technology | Health |
52-Week High | $25.90 | $766.68 |
52-Week Low | $7.28 | $526.44 |
Enterprise Value | $3.85B | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BTDR trades at $9.02, up 3.74% in the last session, with a bearish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $812 million but a net loss of $229 million, missing EPS estimates for four consecutive quarters. Recent news highlights a $4.7 billion AI data center deal in Norway, expanding beyond Bitcoin mining, though gross margins remain pressured.
Outlook is mixed: strong analyst buy consensus (81.82%) and a $22.43 price target suggest upside, but persistent losses, negative cash flow from operations, and high dependency on volatile crypto markets pose significant risks. Investors should weigh growth potential in AI infrastructure against execution challenges and profitability concerns.
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bitdeer Technologies Group
Bitdeer is a world-leading technology company for blockchain and high-performance computing. It provides comprehensive digital asset mining solutions, including cloud mining, hosting, and data center management.
Read more on BTDR →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
